Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.46B |
| 2 |
NVIDIA
NVDA
|
+$2.23B |
| 3 |
Eli Lilly
LLY
|
+$1.36B |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$1.17B |
| 5 |
Amgen
AMGN
|
+$1.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.58B |
| 2 |
AbbVie
ABBV
|
+$1.52B |
| 3 |
Strategy Inc
MSTR
|
+$1.47B |
| 4 |
Constellation Brands
STZ
|
+$1.44B |
| 5 |
RTX Corp
RTX
|
+$1.02B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.77% |
| 2 | Financials | 14.35% |
| 3 | Industrials | 12.97% |
| 4 | Communication Services | 10.31% |
| 5 | Healthcare | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Snap
SNAP
$8.79B
| $422M | 0.08% |
+39,187,434
| New | +$442M |
|
177
Ascendis Pharma A/S
ASND
$16.8B
| $394M | 0.07% |
2,863,249
+753,859
| +36% | +$99.1M |
|
178
Costco
COST
$421B
| $368M | 0.07% |
401,853
+38,787
| +11% | +$36M |
|
179
First Citizens BancShares
FCNCA
$25.7B
| $365M | 0.07% |
172,723
+75,785
| +78% | +$159M |
|
180
Globant
GLOB
$1.67B
| $365M | 0.07% |
1,700,519
+197,064
| +13% | +$43M |
|
181
TransUnion
TRU
$15.2B
| $363M | 0.07% |
3,920,477
-1,464,450
| -27% | -$148M |
|
182
Kraft Heinz
KHC
$29.1B
| $363M | 0.07% |
11,804,086
-13,159
| -0.1% | -$431K |
|
183
Prologis
PLD
$134B
| $358M | 0.07% |
3,382,676
+5,282
| +0.2% | +$607K |
|
184
Public Storage
PSA
$60.4B
| $355M | 0.07% |
1,184,434
-916,547
| -44% | -$304M |
|
185
Armstrong World Industries
AWI
$7.75B
| $351M | 0.07% |
2,485,650
+2,618
| +0.1% | +$385K |
|
|
BLD
186
DELISTED
TopBuild
BLD
| $350M | 0.07% |
1,124,951
-264,741
| -19% | -$97.1M |
|
187
AES
AES
$10.5B
| $347M | 0.07% |
26,958,431
-35,093,715
| -57% | -$524M |
|
188
CRISPR Therapeutics
CRSP
$5.22B
| $344M | 0.06% |
8,743,523
+816,789
| +10% | +$38.6M |
|
189
iShares MSCI EAFE ETF
EFA
$80.2B
| $339M | 0.06% |
4,483,982
+3,589,503
| +401% | +$284M |
|
190
Alnylam Pharmaceuticals
ALNY
$30B
| $334M | 0.06% |
1,418,602
-2,552,261
| -64% | -$671M |
|
191
MKS Inc
MKSI
$20.7B
| $323M | 0.06% |
3,097,676
-62,713
| -2% | -$6.77M |
|
192
Citigroup
C
$231B
| $319M | 0.06% |
4,524,890
+2,704,783
| +149% | +$182M |
|
193
Capital Group Short Duration Municipal Income ETF
CGSM
$1.57B
| $317M | 0.06% |
12,216,565
+182,920
| +2% | +$4.78M |
|
|
SOBO
194
South Bow Corp
SOBO
$7.64B
| $315M | 0.06% |
+13,372,423
| New | +$327M |
|
195
MSCI
MSCI
$40.9B
| $315M | 0.06% |
525,078
-722,114
| -58% | -$433M |
|
|
DFS
196
DELISTED
Discover Financial Services
DFS
| $309M | 0.06% |
1,785,443
-93,233
| -5% | -$15.3M |
|
197
Veralto
VLTO
$23.6B
| $309M | 0.06% |
3,029,536
-5,916
| -0.2% | -$630K |
|
198
Huazhu Hotels Group
HTHT
$12.7B
| $308M | 0.06% |
9,334,577
+1,452,364
| +18% | +$52.6M |
|
199
Capital Group Core Plus Income ETF
CGCP
$8.5B
| $301M | 0.06% |
13,561,469
+2,522,846
| +23% | +$56.9M |
|
200
RELX
RELX
$60.2B
| $292M | 0.05% |
6,433,301
-62,886
| -1% | -$2.95M |
|
Similar funds
Capital International Investors's Q4 2024 Portfolio in Review
As of Q4 2024, Capital International Investors held 473 positions worth $532B, up 2.2% from $521B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Capital International Investors's Q4 2024 filing shows 35 new, 197 increased, 177 reduced and 20 closed positions. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 12,328,262 shares worth $751M. The largest sale was Meta Platforms (Facebook), an estimated $1.58B.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Financials and Industrials.
- Capital International Investors's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 12,328,262 shares worth $751M.
- Capital International Investors added most to Amazon in Q4 2024, an estimated $2.46B increase.
- Capital International Investors's biggest Q4 2024 reduction was Meta Platforms (Facebook), cutting an estimated $1.58B.
- Capital International Investors fully exited Edwards Lifesciences in Q4 2024, selling an estimated $140M.
- Capital International Investors's ten largest holdings make up 33% of its $532B portfolio in Q4 2024.
- Capital International Investors opened 35 new positions and closed 20 in Q4 2024.
- Capital International Investors's portfolio value rose 2.2% quarter-over-quarter to $532B.
Based on Capital International Investors's 13F filing for Q4 2024, filed 13 Feb 2025.